1	3	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Results	_	_	NNS	_	_	_	_	_
2	and	_	_	CC	_	_	_	_	_
3	Discussion	_	_	NN	_	_	_	_	_


1	During	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	drug	_	_	NN	_	_	_	_	_
4	design	_	_	NN	_	_	_	_	_
5	process	_	_	NN	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	to	_	_	TO	_	_	_	_	_
8	assess	_	_	VB	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	potential	_	_	JJ	_	_	_	_	_
11	druggability	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	a	_	_	DT	_	_	_	_	_
14	compound	_	_	NN	_	_	_	_	_
15	as	_	_	IN	_	_	_	_	_
16	a	_	_	DT	_	_	_	_	_
17	new	_	_	JJ	_	_	_	_	_
18	starting	_	_	NN	_	_	_	_	_
19	point	_	_	NN	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	some	_	_	DT	_	_	_	_	_
22	initial	_	_	JJ	_	_	_	_	_
23	rules	_	_	NNS	_	_	_	_	_
24	like	_	_	IN	_	_	_	_	_
25	drug-likeness	_	_	NN	_	_	_	_	_
26	(	_	_	-LRB-	_	_	_	_	_
27	as	_	_	IN	_	_	_	_	_
28	defined	_	_	VBN	_	_	_	_	_
29	by	_	_	IN	_	_	_	_	_
30	Lipinski	_	_	NNP	_	_	_	_	_
31	and	_	_	CC	_	_	_	_	_
32	colleagues	_	_	NNS	_	_	_	_	_
33	in	_	_	IN	_	_	_	_	_
34	1997	_	_	CD	_	_	_	_	_
35	)	_	_	-RRB-	_	_	_	_	_
36	,	_	_	,	_	_	_	_	_
37	lead-likeness	_	_	NN	_	_	_	_	_
38	(	_	_	-LRB-	_	_	_	_	_
39	as	_	_	IN	_	_	_	_	_
40	defined	_	_	VBN	_	_	_	_	_
41	by	_	_	IN	_	_	_	_	_
42	Oprea	_	_	NNP	_	_	_	_	_
43	)	_	_	-RRB-	_	_	_	_	_
44	and	_	_	CC	_	_	_	_	_
45	known	_	_	VBN	_	_	_	_	_
46	drug	_	_	NN	_	_	_	_	_
47	space	_	_	NN	_	_	_	_	_
48	,	_	_	,	_	_	_	_	_
49	are	_	_	VBP	_	_	_	_	_
50	usually	_	_	RB	_	_	_	_	_
51	applied	_	_	VBN	_	_	_	_	_
52	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	general	_	_	JJ	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	rules	_	_	NNS	_	_	_	_	_
6	to	_	_	TO	_	_	_	_	_
7	characterise/filter	_	_	NN	_	_	_	_	_
8	compound	_	_	NN	_	_	_	_	_
9	collections	_	_	NNS	_	_	_	_	_
10	are	_	_	VBP	_	_	_	_	_
11	based	_	_	VBN	_	_	_	_	_
12	upon	_	_	IN	_	_	_	_	_
13	physicochemical	_	_	JJ	_	_	_	_	_
14	parameters	_	_	NNS	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	e.	_	_	FW	_	_	_	_	_
17	g.	_	_	FW	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	logP	_	_	NN	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	logS	_	_	NNS	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	MW	_	_	NNP	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	TPSA	_	_	NNP	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	MR	_	_	NNP	_	_	_	_	_
28	,	_	_	,	_	_	_	_	_
29	RotN	_	_	NNP	_	_	_	_	_
30	,	_	_	,	_	_	_	_	_
31	HBA	_	_	NNP	_	_	_	_	_
32	and	_	_	CC	_	_	_	_	_
33	HBD	_	_	NNP	_	_	_	_	_
34	,	_	_	,	_	_	_	_	_
35	among	_	_	IN	_	_	_	_	_
36	others	_	_	NNS	_	_	_	_	_
37	.	_	_	.	_	_	_	_	_


1	As	_	_	IN	_	_	_	_	_
2	a	_	_	DT	_	_	_	_	_
3	result	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	it	_	_	PRP	_	_	_	_	_
6	would	_	_	MD	_	_	_	_	_
7	be	_	_	VB	_	_	_	_	_
8	interesting	_	_	JJ	_	_	_	_	_
9	to	_	_	TO	_	_	_	_	_
10	assess	_	_	VB	_	_	_	_	_
11	how	_	_	WRB	_	_	_	_	_
12	proteasome	_	_	JJ	_	_	_	_	_
13	inhibitors	_	_	NNS	_	_	_	_	_
14	are	_	_	VBP	_	_	_	_	_
15	positioned	_	_	VBN	_	_	_	_	_
16	with	_	_	IN	_	_	_	_	_
17	respect	_	_	NN	_	_	_	_	_
18	to	_	_	TO	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	typically	_	_	RB	_	_	_	_	_
21	expected	_	_	VBN	_	_	_	_	_
22	“	_	_	``	_	_	_	_	_
23	drug-like	_	_	JJ	_	_	_	_	_
24	”	_	_	''	_	_	_	_	_
25	chemical	_	_	JJ	_	_	_	_	_
26	space	_	_	NN	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	To	_	_	TO	_	_	_	_	_
2	do	_	_	VB	_	_	_	_	_
3	so	_	_	RB	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	we	_	_	PRP	_	_	_	_	_
6	performed	_	_	VBD	_	_	_	_	_
7	a	_	_	DT	_	_	_	_	_
8	comprehensive	_	_	JJ	_	_	_	_	_
9	analysis	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	680	_	_	CD	_	_	_	_	_
13	small-molecules	_	_	NNS	_	_	_	_	_
14	proteasome	_	_	NN	_	_	_	_	_
15	inhibitors	_	_	NNS	_	_	_	_	_
16	dataset	_	_	NN	_	_	_	_	_
17	spanning	_	_	VBG	_	_	_	_	_
18	a	_	_	DT	_	_	_	_	_
19	large	_	_	JJ	_	_	_	_	_
20	range	_	_	NN	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	activity	_	_	NN	_	_	_	_	_
23	(	_	_	-LRB-	_	_	_	_	_
24	0.08	_	_	CD	_	_	_	_	_
25	nM	_	_	NN	_	_	_	_	_
26	<	_	_	SYM	_	_	_	_	_
27	IC50	_	_	NN	_	_	_	_	_
28	≤	_	_	SYM	_	_	_	_	_
29	150,000	_	_	CD	_	_	_	_	_
30	nM	_	_	NN	_	_	_	_	_
31	)	_	_	-RRB-	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	entailed	_	_	VBD	_	_	_	_	_
3	looking	_	_	VBG	_	_	_	_	_
4	at	_	_	IN	_	_	_	_	_
5	chemical	_	_	JJ	_	_	_	_	_
6	space	_	_	NN	_	_	_	_	_
7	distribution	_	_	NN	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	scaffold	_	_	NN	_	_	_	_	_
10	similarity	_	_	NN	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	extraction	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	chemical	_	_	JJ	_	_	_	_	_
16	rules	_	_	NNS	_	_	_	_	_
17	with	_	_	IN	_	_	_	_	_
18	machine	_	_	NN	_	_	_	_	_
19	learning	_	_	NN	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	using	_	_	VBG	_	_	_	_	_
22	either	_	_	CC	_	_	_	_	_
23	direct	_	_	JJ	_	_	_	_	_
24	structural	_	_	JJ	_	_	_	_	_
25	information	_	_	NN	_	_	_	_	_
26	(	_	_	-LRB-	_	_	_	_	_
27	scaffolds	_	_	NNS	_	_	_	_	_
28	and	_	_	CC	_	_	_	_	_
29	Morgan	_	_	NNP	_	_	_	_	_
30	fingerprints	_	_	NNS	_	_	_	_	_
31	)	_	_	-RRB-	_	_	_	_	_
32	or	_	_	CC	_	_	_	_	_
33	being	_	_	VBG	_	_	_	_	_
34	based	_	_	VBN	_	_	_	_	_
35	on	_	_	IN	_	_	_	_	_
36	21	_	_	CD	_	_	_	_	_
37	general	_	_	JJ	_	_	_	_	_
38	molecular	_	_	JJ	_	_	_	_	_
39	(	_	_	-LRB-	_	_	_	_	_
40	QuaSAR	_	_	NNP	_	_	_	_	_
41	)	_	_	-RRB-	_	_	_	_	_
42	descriptors	_	_	NNS	_	_	_	_	_
43	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	set	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	analyses	_	_	NNS	_	_	_	_	_
5	was	_	_	VBD	_	_	_	_	_
6	ultimately	_	_	RB	_	_	_	_	_
7	employed	_	_	VBN	_	_	_	_	_
8	to	_	_	TO	_	_	_	_	_
9	produce	_	_	VB	_	_	_	_	_
10	meaningful	_	_	JJ	_	_	_	_	_
11	chemical	_	_	JJ	_	_	_	_	_
12	patterns	_	_	NNS	_	_	_	_	_
13	that	_	_	WDT	_	_	_	_	_
14	are	_	_	VBP	_	_	_	_	_
15	correlated	_	_	VBN	_	_	_	_	_
16	with	_	_	IN	_	_	_	_	_
17	proteasome	_	_	NN	_	_	_	_	_
18	inhibitory	_	_	JJ	_	_	_	_	_
19	activity	_	_	NN	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	dataset	_	_	NN	_	_	_	_	_
3	comprises	_	_	VBZ	_	_	_	_	_
4	only	_	_	RB	_	_	_	_	_
5	human	_	_	JJ	_	_	_	_	_
6	proteasome	_	_	NN	_	_	_	_	_
7	activity	_	_	NN	_	_	_	_	_
8	data	_	_	NNS	_	_	_	_	_
9	for	_	_	IN	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	CT-L	_	_	NNP	_	_	_	_	_
12	catalytic	_	_	JJ	_	_	_	_	_
13	site	_	_	NN	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	as	_	_	IN	_	_	_	_	_
16	this	_	_	DT	_	_	_	_	_
17	is	_	_	VBZ	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	only	_	_	JJ	_	_	_	_	_
20	site	_	_	NN	_	_	_	_	_
21	with	_	_	IN	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	largest	_	_	JJS	_	_	_	_	_
24	number	_	_	NN	_	_	_	_	_
25	of	_	_	IN	_	_	_	_	_
26	compounds	_	_	NNS	_	_	_	_	_
27	,	_	_	,	_	_	_	_	_
28	and	_	_	CC	_	_	_	_	_
29	is	_	_	VBZ	_	_	_	_	_
30	divided	_	_	VBN	_	_	_	_	_
31	into	_	_	IN	_	_	_	_	_
32	four	_	_	CD	_	_	_	_	_
33	classes	_	_	NNS	_	_	_	_	_
34	.	_	_	.	_	_	_	_	_


1	Full	_	_	JJ	_	_	_	_	_
2	data	_	_	NNS	_	_	_	_	_
3	are	_	_	VBP	_	_	_	_	_
4	available	_	_	JJ	_	_	_	_	_
5	in	_	_	IN	_	_	_	_	_
6	Table	_	_	NNP	_	_	_	_	_
7	S1	_	_	NNP	_	_	_	_	_
8	.	_	_	.	_	_	_	_	_


1	Analysis	_	_	NN	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	chemical	_	_	JJ	_	_	_	_	_
4	space	_	_	NN	_	_	_	_	_
5	distribution	_	_	NN	_	_	_	_	_
6	and	_	_	CC	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	scaffold	_	_	NN	_	_	_	_	_
9	similarity	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	proteasome	_	_	NN	_	_	_	_	_
12	inhibitors	_	_	NNS	_	_	_	_	_
13	.	_	_	.	_	_	_	_	_


1	First	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	we	_	_	PRP	_	_	_	_	_
4	analyzed	_	_	VBD	_	_	_	_	_
5	human	_	_	JJ	_	_	_	_	_
6	proteasome	_	_	NN	_	_	_	_	_
7	inhibitors	_	_	NNS	_	_	_	_	_
8	’	_	_	POS	_	_	_	_	_
9	chemical	_	_	JJ	_	_	_	_	_
10	space	_	_	NN	_	_	_	_	_
11	distribution	_	_	NN	_	_	_	_	_
12	.	_	_	.	_	_	_	_	_


1	To	_	_	TO	_	_	_	_	_
2	address	_	_	VB	_	_	_	_	_
3	this	_	_	DT	_	_	_	_	_
4	analysis	_	_	NN	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	chemical	_	_	JJ	_	_	_	_	_
7	space	_	_	NN	_	_	_	_	_
8	was	_	_	VBD	_	_	_	_	_
9	defined	_	_	VBN	_	_	_	_	_
10	by	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	t-SNE	_	_	NNP	_	_	_	_	_
13	calculation	_	_	NN	_	_	_	_	_
14	applied	_	_	VBN	_	_	_	_	_
15	to	_	_	TO	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	21	_	_	CD	_	_	_	_	_
18	calculated	_	_	VBN	_	_	_	_	_
19	molecular	_	_	JJ	_	_	_	_	_
20	descriptors	_	_	NNS	_	_	_	_	_
21	listed	_	_	VBN	_	_	_	_	_
22	in	_	_	IN	_	_	_	_	_
23	the	_	_	DT	_	_	_	_	_
24	Supplementary	_	_	NNP	_	_	_	_	_
25	Information	_	_	NN	_	_	_	_	_
26	(	_	_	-LRB-	_	_	_	_	_
27	Table	_	_	NN	_	_	_	_	_
28	S1	_	_	NN	_	_	_	_	_
29	)	_	_	-RRB-	_	_	_	_	_
30	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	proximity	_	_	NN	_	_	_	_	_
3	in	_	_	IN	_	_	_	_	_
4	a	_	_	DT	_	_	_	_	_
5	t-SNE	_	_	NNP	_	_	_	_	_
6	plot	_	_	NN	_	_	_	_	_
7	is	_	_	VBZ	_	_	_	_	_
8	relative	_	_	JJ	_	_	_	_	_
9	in	_	_	IN	_	_	_	_	_
10	nature	_	_	NN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	distance	_	_	NN	_	_	_	_	_
15	between	_	_	IN	_	_	_	_	_
16	points	_	_	NNS	_	_	_	_	_
17	simply	_	_	RB	_	_	_	_	_
18	represents	_	_	VBZ	_	_	_	_	_
19	relative	_	_	JJ	_	_	_	_	_
20	proximity	_	_	NN	_	_	_	_	_
21	(	_	_	-LRB-	_	_	_	_	_
22	i.	_	_	FW	_	_	_	_	_
23	e.	_	_	FW	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	it	_	_	PRP	_	_	_	_	_
26	is	_	_	VBZ	_	_	_	_	_
27	not	_	_	RB	_	_	_	_	_
28	a	_	_	DT	_	_	_	_	_
29	direct	_	_	JJ	_	_	_	_	_
30	scaling	_	_	NN	_	_	_	_	_
31	from	_	_	IN	_	_	_	_	_
32	real	_	_	JJ	_	_	_	_	_
33	distances	_	_	NNS	_	_	_	_	_
34	in	_	_	IN	_	_	_	_	_
35	the	_	_	DT	_	_	_	_	_
36	21	_	_	CD	_	_	_	_	_
37	dimensional	_	_	JJ	_	_	_	_	_
38	space	_	_	NN	_	_	_	_	_
39	)	_	_	-RRB-	_	_	_	_	_
40	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_


1	Figure	_	_	NN	_	_	_	_	_
2	4	_	_	CD	_	_	_	_	_


1	(	_	_	-LRB-	_	_	_	_	_
2	left	_	_	RB	_	_	_	_	_
3	)	_	_	-RRB-	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	difference	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	distribution	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	four	_	_	CD	_	_	_	_	_
11	activity	_	_	NN	_	_	_	_	_
12	classes	_	_	NNS	_	_	_	_	_
13	is	_	_	VBZ	_	_	_	_	_
14	easily	_	_	RB	_	_	_	_	_
15	perceptible	_	_	JJ	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	with	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	most	_	_	RBS	_	_	_	_	_
20	active	_	_	JJ	_	_	_	_	_
21	compounds	_	_	NNS	_	_	_	_	_
22	(	_	_	-LRB-	_	_	_	_	_
23	class	_	_	NN	_	_	_	_	_
24	A	_	_	NN	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	purple	_	_	NN	_	_	_	_	_
27	)	_	_	-RRB-	_	_	_	_	_
28	having	_	_	VBG	_	_	_	_	_
29	close	_	_	JJ	_	_	_	_	_
30	to	_	_	TO	_	_	_	_	_
31	half	_	_	NN	_	_	_	_	_
32	of	_	_	IN	_	_	_	_	_
33	its	_	_	PRP$	_	_	_	_	_
34	compounds	_	_	NNS	_	_	_	_	_
35	(	_	_	-LRB-	_	_	_	_	_
36	~47	_	_	CD	_	_	_	_	_
37	%	_	_	NN	_	_	_	_	_
38	)	_	_	-RRB-	_	_	_	_	_
39	in	_	_	IN	_	_	_	_	_
40	the	_	_	DT	_	_	_	_	_
41	top-right	_	_	JJ	_	_	_	_	_
42	quadrant	_	_	NN	_	_	_	_	_
43	of	_	_	IN	_	_	_	_	_
44	the	_	_	DT	_	_	_	_	_
45	plot	_	_	NN	_	_	_	_	_
46	,	_	_	,	_	_	_	_	_
47	while	_	_	IN	_	_	_	_	_
48	the	_	_	DT	_	_	_	_	_
49	least	_	_	RBS	_	_	_	_	_
50	active	_	_	JJ	_	_	_	_	_
51	compounds	_	_	NNS	_	_	_	_	_
52	(	_	_	-LRB-	_	_	_	_	_
53	class	_	_	NN	_	_	_	_	_
54	D	_	_	NN	_	_	_	_	_
55	,	_	_	,	_	_	_	_	_
56	orange	_	_	NN	_	_	_	_	_
57	)	_	_	-RRB-	_	_	_	_	_
58	are	_	_	VBP	_	_	_	_	_
59	mainly	_	_	RB	_	_	_	_	_
60	concentrated	_	_	VBN	_	_	_	_	_
61	in	_	_	IN	_	_	_	_	_
62	the	_	_	DT	_	_	_	_	_
63	bottom-left	_	_	JJ	_	_	_	_	_
64	quadrant	_	_	NN	_	_	_	_	_
65	(	_	_	-LRB-	_	_	_	_	_
66	~58	_	_	CD	_	_	_	_	_
67	%	_	_	NN	_	_	_	_	_
68	of	_	_	IN	_	_	_	_	_
69	class	_	_	NN	_	_	_	_	_
70	D	_	_	NN	_	_	_	_	_
71	compounds	_	_	NNS	_	_	_	_	_
72	)	_	_	-RRB-	_	_	_	_	_
73	,	_	_	,	_	_	_	_	_
74	as	_	_	IN	_	_	_	_	_
75	quantified	_	_	VBN	_	_	_	_	_
76	in	_	_	IN	_	_	_	_	_


1	Figure	_	_	NN	_	_	_	_	_
2	4	_	_	CD	_	_	_	_	_


1	(	_	_	-LRB-	_	_	_	_	_
2	right	_	_	RB	_	_	_	_	_
3	)	_	_	-RRB-	_	_	_	_	_
4	.	_	_	.	_	_	_	_	_


1	Classes	_	_	NNS	_	_	_	_	_
2	B	_	_	NN	_	_	_	_	_
3	(	_	_	-LRB-	_	_	_	_	_
4	blue	_	_	JJ	_	_	_	_	_
5	)	_	_	-RRB-	_	_	_	_	_
6	and	_	_	CC	_	_	_	_	_
7	C	_	_	NNP	_	_	_	_	_
8	(	_	_	-LRB-	_	_	_	_	_
9	green	_	_	NN	_	_	_	_	_
10	)	_	_	-RRB-	_	_	_	_	_
11	have	_	_	VBP	_	_	_	_	_
12	a	_	_	DT	_	_	_	_	_
13	more	_	_	RBR	_	_	_	_	_
14	disperse	_	_	JJ	_	_	_	_	_
15	distribution	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	but	_	_	CC	_	_	_	_	_
18	show	_	_	VBP	_	_	_	_	_
19	some	_	_	DT	_	_	_	_	_
20	higher	_	_	JJR	_	_	_	_	_
21	density	_	_	NN	_	_	_	_	_
22	areas	_	_	NNS	_	_	_	_	_
23	close	_	_	JJ	_	_	_	_	_
24	to	_	_	TO	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	bottom-left	_	_	JJ	_	_	_	_	_
27	corner	_	_	NN	_	_	_	_	_
28	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	indicates	_	_	VBZ	_	_	_	_	_
3	that	_	_	IN	_	_	_	_	_
4	class	_	_	NN	_	_	_	_	_
5	D	_	_	NNP	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	for	_	_	IN	_	_	_	_	_
8	example	_	_	NN	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	is	_	_	VBZ	_	_	_	_	_
11	fundamentally	_	_	RB	_	_	_	_	_
12	different	_	_	JJ	_	_	_	_	_
13	to	_	_	TO	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	remaining	_	_	VBG	_	_	_	_	_
16	classes	_	_	NNS	_	_	_	_	_
17	from	_	_	IN	_	_	_	_	_
18	a	_	_	DT	_	_	_	_	_
19	structural	_	_	JJ	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	physicochemical	_	_	JJ	_	_	_	_	_
22	level	_	_	NN	_	_	_	_	_
23	,	_	_	,	_	_	_	_	_
24	and	_	_	CC	_	_	_	_	_
25	therefore	_	_	RB	_	_	_	_	_
26	supports	_	_	VBZ	_	_	_	_	_
27	the	_	_	DT	_	_	_	_	_
28	existence	_	_	NN	_	_	_	_	_
29	of	_	_	IN	_	_	_	_	_
30	a	_	_	DT	_	_	_	_	_
31	SAR	_	_	NN	_	_	_	_	_
32	in	_	_	IN	_	_	_	_	_
33	the	_	_	DT	_	_	_	_	_
34	proteasome	_	_	NN	_	_	_	_	_
35	inhibitors	_	_	NNS	_	_	_	_	_
36	developed	_	_	VBN	_	_	_	_	_
37	in	_	_	IN	_	_	_	_	_
38	the	_	_	DT	_	_	_	_	_
39	last	_	_	JJ	_	_	_	_	_
40	20	_	_	CD	_	_	_	_	_
41	years	_	_	NNS	_	_	_	_	_
42	.	_	_	.	_	_	_	_	_


1	Additionally	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	no	_	_	DT	_	_	_	_	_
4	particular	_	_	JJ	_	_	_	_	_
5	cluster	_	_	NN	_	_	_	_	_
6	was	_	_	VBD	_	_	_	_	_
7	formed	_	_	VBN	_	_	_	_	_
8	with	_	_	IN	_	_	_	_	_
9	a	_	_	DT	_	_	_	_	_
10	single	_	_	JJ	_	_	_	_	_
11	class	_	_	NN	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	which	_	_	WDT	_	_	_	_	_
14	means	_	_	VBZ	_	_	_	_	_
15	there	_	_	EX	_	_	_	_	_
16	is	_	_	VBZ	_	_	_	_	_
17	no	_	_	DT	_	_	_	_	_
18	particular	_	_	JJ	_	_	_	_	_
19	location	_	_	NN	_	_	_	_	_
20	in	_	_	IN	_	_	_	_	_
21	chemical	_	_	JJ	_	_	_	_	_
22	space	_	_	NN	_	_	_	_	_
23	(	_	_	-LRB-	_	_	_	_	_
24	at	_	_	IN	_	_	_	_	_
25	least	_	_	JJS	_	_	_	_	_
26	one	_	_	CD	_	_	_	_	_
27	that	_	_	WDT	_	_	_	_	_
28	is	_	_	VBZ	_	_	_	_	_
29	defined	_	_	VBN	_	_	_	_	_
30	by	_	_	IN	_	_	_	_	_
31	the	_	_	DT	_	_	_	_	_
32	descriptors	_	_	NNS	_	_	_	_	_
33	that	_	_	WDT	_	_	_	_	_
34	we	_	_	PRP	_	_	_	_	_
35	considered	_	_	VBD	_	_	_	_	_
36	)	_	_	-RRB-	_	_	_	_	_
37	which	_	_	WDT	_	_	_	_	_
38	is	_	_	VBZ	_	_	_	_	_
39	reserved	_	_	VBN	_	_	_	_	_
40	to	_	_	TO	_	_	_	_	_
41	one	_	_	CD	_	_	_	_	_
42	single	_	_	JJ	_	_	_	_	_
43	class	_	_	NN	_	_	_	_	_
44	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	observation	_	_	NN	_	_	_	_	_
3	indicates	_	_	VBZ	_	_	_	_	_
4	that	_	_	IN	_	_	_	_	_
5	carrying	_	_	VBG	_	_	_	_	_
6	out	_	_	RP	_	_	_	_	_
7	compound	_	_	NN	_	_	_	_	_
8	selection	_	_	NN	_	_	_	_	_
9	biased	_	_	VBN	_	_	_	_	_
10	for	_	_	IN	_	_	_	_	_
11	physicochemical	_	_	JJ	_	_	_	_	_
12	similarity	_	_	NN	_	_	_	_	_
13	to	_	_	TO	_	_	_	_	_
14	known	_	_	VBN	_	_	_	_	_
15	inhibitors	_	_	NNS	_	_	_	_	_
16	might	_	_	MD	_	_	_	_	_
17	be	_	_	VB	_	_	_	_	_
18	a	_	_	DT	_	_	_	_	_
19	good	_	_	JJ	_	_	_	_	_
20	initial	_	_	JJ	_	_	_	_	_
21	filter	_	_	NN	_	_	_	_	_
22	to	_	_	TO	_	_	_	_	_
23	enrich	_	_	VB	_	_	_	_	_
24	the	_	_	DT	_	_	_	_	_
25	set	_	_	NN	_	_	_	_	_
26	of	_	_	IN	_	_	_	_	_
27	compound	_	_	NN	_	_	_	_	_
28	candidates	_	_	NNS	_	_	_	_	_
29	with	_	_	IN	_	_	_	_	_
30	active	_	_	JJ	_	_	_	_	_
31	hits	_	_	NNS	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	Next	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	we	_	_	PRP	_	_	_	_	_
4	wanted	_	_	VBD	_	_	_	_	_
5	to	_	_	TO	_	_	_	_	_
6	investigate	_	_	VB	_	_	_	_	_
7	what	_	_	WP	_	_	_	_	_
8	characteristics	_	_	NNS	_	_	_	_	_
9	are	_	_	VBP	_	_	_	_	_
10	responsible	_	_	JJ	_	_	_	_	_
11	for	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	differences	_	_	NNS	_	_	_	_	_
14	between	_	_	IN	_	_	_	_	_
15	classes	_	_	NNS	_	_	_	_	_
16	in	_	_	IN	_	_	_	_	_
17	the	_	_	DT	_	_	_	_	_
18	chemical	_	_	JJ	_	_	_	_	_
19	space	_	_	NN	_	_	_	_	_
20	distribution	_	_	NN	_	_	_	_	_
21	.	_	_	.	_	_	_	_	_


1	Upon	_	_	IN	_	_	_	_	_
2	applying	_	_	VBG	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	Tc	_	_	NNP	_	_	_	_	_
5	to	_	_	TO	_	_	_	_	_
6	characterize	_	_	VB	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	similarity	_	_	NN	_	_	_	_	_
9	between	_	_	IN	_	_	_	_	_
10	Murcko	_	_	NNP	_	_	_	_	_
11	scaffolds	_	_	NNS	_	_	_	_	_
12	within	_	_	IN	_	_	_	_	_
13	each	_	_	DT	_	_	_	_	_
14	class	_	_	NN	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	we	_	_	PRP	_	_	_	_	_
17	observed	_	_	VBD	_	_	_	_	_
18	a	_	_	DT	_	_	_	_	_
19	high	_	_	JJ	_	_	_	_	_
20	diversity	_	_	NN	_	_	_	_	_
21	in	_	_	IN	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	dataset	_	_	NN	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	not	_	_	RB	_	_	_	_	_
26	just	_	_	RB	_	_	_	_	_
27	within	_	_	IN	_	_	_	_	_
28	each	_	_	DT	_	_	_	_	_
29	class	_	_	NN	_	_	_	_	_
30	,	_	_	,	_	_	_	_	_
31	but	_	_	CC	_	_	_	_	_
32	also	_	_	RB	_	_	_	_	_
33	between	_	_	IN	_	_	_	_	_
34	the	_	_	DT	_	_	_	_	_
35	different	_	_	JJ	_	_	_	_	_
36	classes	_	_	NNS	_	_	_	_	_
37	,	_	_	,	_	_	_	_	_
38	with	_	_	IN	_	_	_	_	_
39	most	_	_	JJS	_	_	_	_	_
40	pairs	_	_	NNS	_	_	_	_	_
41	of	_	_	IN	_	_	_	_	_
42	compounds	_	_	NNS	_	_	_	_	_
43	showing	_	_	VBG	_	_	_	_	_
44	a	_	_	DT	_	_	_	_	_
45	Tc	_	_	NN	_	_	_	_	_
46	below	_	_	RB	_	_	_	_	_
47	0.5	_	_	CD	_	_	_	_	_
48	that	_	_	WDT	_	_	_	_	_
49	represents	_	_	VBZ	_	_	_	_	_
50	a	_	_	DT	_	_	_	_	_
51	considerable	_	_	JJ	_	_	_	_	_
52	dissimilarity	_	_	NN	_	_	_	_	_
53	(	_	_	-LRB-	_	_	_	_	_


1	Figure	_	_	NN	_	_	_	_	_
2	5	_	_	CD	_	_	_	_	_


1	)	_	_	-RRB-	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Nonetheless	_	_	RB	_	_	_	_	_
2	a	_	_	DT	_	_	_	_	_
3	clear	_	_	JJ	_	_	_	_	_
4	trend	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	correlation	_	_	NN	_	_	_	_	_
7	between	_	_	IN	_	_	_	_	_
8	activity	_	_	NN	_	_	_	_	_
9	and	_	_	CC	_	_	_	_	_
10	similarity	_	_	NN	_	_	_	_	_
11	is	_	_	VBZ	_	_	_	_	_
12	observed	_	_	VBN	_	_	_	_	_
13	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	scaffolds	_	_	NNS	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	class	_	_	NN	_	_	_	_	_
5	B	_	_	NN	_	_	_	_	_
6	differ	_	_	VBP	_	_	_	_	_
7	negligibly	_	_	RB	_	_	_	_	_
8	from	_	_	IN	_	_	_	_	_
9	class	_	_	NN	_	_	_	_	_
10	A	_	_	NN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	however	_	_	RB	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	class	_	_	NN	_	_	_	_	_
15	C	_	_	NNP	_	_	_	_	_
16	shows	_	_	VBZ	_	_	_	_	_
17	a	_	_	DT	_	_	_	_	_
18	two-peak	_	_	JJ	_	_	_	_	_
19	distribution	_	_	NN	_	_	_	_	_
20	which	_	_	WDT	_	_	_	_	_
21	suggests	_	_	VBZ	_	_	_	_	_
22	it	_	_	PRP	_	_	_	_	_
23	contains	_	_	VBZ	_	_	_	_	_
24	scaffolds	_	_	NNS	_	_	_	_	_
25	similar	_	_	JJ	_	_	_	_	_
26	to	_	_	TO	_	_	_	_	_
27	both	_	_	DT	_	_	_	_	_
28	classes	_	_	NNS	_	_	_	_	_
29	A/B	_	_	NNP	_	_	_	_	_
30	,	_	_	,	_	_	_	_	_
31	as	_	_	RB	_	_	_	_	_
32	well	_	_	RB	_	_	_	_	_
33	as	_	_	IN	_	_	_	_	_
34	with	_	_	IN	_	_	_	_	_
35	lower	_	_	JJR	_	_	_	_	_
36	activity	_	_	NN	_	_	_	_	_
37	compounds	_	_	NNS	_	_	_	_	_
38	(	_	_	-LRB-	_	_	_	_	_
39	class	_	_	NN	_	_	_	_	_
40	D	_	_	NN	_	_	_	_	_
41	)	_	_	-RRB-	_	_	_	_	_
42	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	probably	_	_	RB	_	_	_	_	_
4	a	_	_	DT	_	_	_	_	_
5	result	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	practical	_	_	JJ	_	_	_	_	_
9	strategies	_	_	NNS	_	_	_	_	_
10	applied	_	_	VBN	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	medicinal	_	_	JJ	_	_	_	_	_
13	chemistry	_	_	NN	_	_	_	_	_
14	where	_	_	WRB	_	_	_	_	_
15	inactive	_	_	JJ	_	_	_	_	_
16	structures	_	_	NNS	_	_	_	_	_
17	are	_	_	VBP	_	_	_	_	_
18	modified/derivatized	_	_	VBN	_	_	_	_	_
19	to	_	_	TO	_	_	_	_	_
20	meet	_	_	VB	_	_	_	_	_
21	or	_	_	CC	_	_	_	_	_
22	better	_	_	RBR	_	_	_	_	_
23	resemble	_	_	VB	_	_	_	_	_
24	substructures	_	_	NNS	_	_	_	_	_
25	seen	_	_	VBN	_	_	_	_	_
26	among	_	_	IN	_	_	_	_	_
27	actives	_	_	NNS	_	_	_	_	_
28	,	_	_	,	_	_	_	_	_
29	thus	_	_	RB	_	_	_	_	_
30	creating	_	_	VBG	_	_	_	_	_
31	this	_	_	DT	_	_	_	_	_
32	transition	_	_	NN	_	_	_	_	_
33	from	_	_	IN	_	_	_	_	_
34	A	_	_	DT	_	_	_	_	_
35	to	_	_	TO	_	_	_	_	_
36	D.	_	_	NNP	_	_	_	_	_
37	As	_	_	IN	_	_	_	_	_
38	concluded	_	_	VBN	_	_	_	_	_
39	from	_	_	IN	_	_	_	_	_
40	the	_	_	DT	_	_	_	_	_
41	chemical	_	_	JJ	_	_	_	_	_
42	space	_	_	NN	_	_	_	_	_
43	observation	_	_	NN	_	_	_	_	_
44	,	_	_	,	_	_	_	_	_
45	this	_	_	DT	_	_	_	_	_
46	also	_	_	RB	_	_	_	_	_
47	shows	_	_	VBZ	_	_	_	_	_
48	that	_	_	IN	_	_	_	_	_
49	functionalizing	_	_	VBG	_	_	_	_	_
50	scaffolds	_	_	NNS	_	_	_	_	_
51	from	_	_	IN	_	_	_	_	_
52	more	_	_	RBR	_	_	_	_	_
53	potent	_	_	JJ	_	_	_	_	_
54	compounds	_	_	NNS	_	_	_	_	_
55	(	_	_	-LRB-	_	_	_	_	_
56	class	_	_	NN	_	_	_	_	_
57	A/B	_	_	NNP	_	_	_	_	_
58	)	_	_	-RRB-	_	_	_	_	_
59	might	_	_	MD	_	_	_	_	_
60	be	_	_	VB	_	_	_	_	_
61	a	_	_	DT	_	_	_	_	_
62	feasible	_	_	JJ	_	_	_	_	_
63	initial	_	_	JJ	_	_	_	_	_
64	strategy	_	_	NN	_	_	_	_	_
65	to	_	_	TO	_	_	_	_	_
66	find	_	_	VB	_	_	_	_	_
67	new	_	_	JJ	_	_	_	_	_
68	actives	_	_	NNS	_	_	_	_	_
69	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	selected	_	_	VBN	_	_	_	_	_
4	scaffolds	_	_	NNS	_	_	_	_	_
5	should	_	_	MD	_	_	_	_	_
6	also	_	_	RB	_	_	_	_	_
7	be	_	_	VB	_	_	_	_	_
8	sufficiently	_	_	RB	_	_	_	_	_
9	dissimilar	_	_	JJ	_	_	_	_	_
10	to	_	_	TO	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	lower	_	_	JJR	_	_	_	_	_
13	activity	_	_	NN	_	_	_	_	_
14	scaffolds	_	_	NNS	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	effectively	_	_	RB	_	_	_	_	_
17	avoiding	_	_	VBG	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	right-end	_	_	JJ	_	_	_	_	_
20	tail	_	_	NN	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	class	_	_	NN	_	_	_	_	_
24	D	_	_	NN	_	_	_	_	_
25	(	_	_	-LRB-	_	_	_	_	_
26	i.	_	_	FW	_	_	_	_	_
27	e.	_	_	FW	_	_	_	_	_
28	,	_	_	,	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	most	_	_	RBS	_	_	_	_	_
31	similar	_	_	JJ	_	_	_	_	_
32	scaffolds	_	_	NNS	_	_	_	_	_
33	to	_	_	TO	_	_	_	_	_
34	A	_	_	DT	_	_	_	_	_
35	,	_	_	,	_	_	_	_	_
36	which	_	_	WDT	_	_	_	_	_
37	are	_	_	VBP	_	_	_	_	_
38	still	_	_	RB	_	_	_	_	_
39	largely	_	_	RB	_	_	_	_	_
40	inactive	_	_	JJ	_	_	_	_	_
41	)	_	_	-RRB-	_	_	_	_	_
42	.	_	_	.	_	_	_	_	_

